Role of Serum Vascular Endothelial Growth Factor (VEGF) as a Potential Biomarker of Response to Immune Checkpoint Inhibitor Therapy in Advanced Melanoma: Results of a Pilot Study

Background: The development of biomarkers predictive of response to immune checkpoint inhibitor (ICI) therapies in advanced melanoma is an area of great interest in oncology. Our study evaluated the potential role of serum vascular endothelial growth factor (VEGF) as a predictive biomarker of clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Khattak, Muhammad A., Abed, Afaf, Reid, Anna L., McEvoy, Ashleigh C., Millward, Michael, Ziman, Melanie, Gray, Elin S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338663/
https://www.ncbi.nlm.nih.gov/pubmed/32695680
http://dx.doi.org/10.3389/fonc.2020.01041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338663/
https://www.ncbi.nlm.nih.gov/pubmed/32695680
http://dx.doi.org/10.3389/fonc.2020.01041

Ejemplares similares